Insilico Medicine
AI-Designed Drug Offers Hope for Inflammatory Bowel Disease Treatment
NeelRatan
Insilico Medicine has announced positive results from Phase I trials of ISM5411, an AI-designed drug aimed at treating inflammatory bowel disease. The studies conducted in Australia and China show promise for this innovative treatment, reflecting advancements in generative AI for drug development.
